It revealed that mesalamine represses mi-155 expression provoked by inflammation and raises the MMR protein levels, implying a role in cancer prevention for patients with primary sclerosing cholangitis (PSC) and simultaneous UC [21]. This evidence concerns the gene MRC1 and cancer.